Anti-Mouse F4/80 – Purified in vivo GOLD™ Functional Grade

Anti-Mouse F4/80 – Purified in vivo GOLD™ Functional Grade

Product No.: F481

- -
- -
Clone
Cl:A3-1
Target
F4/80
Formats AvailableView All
Product Type
Hybridoma Monoclonal Antibody
Alternate Names
Adhesion G protein-coupled receptor E1 (ADGRE1), EMR1, F4/80, Gpf480
Isotype
Rat IgG2b κ
Applications
FA
,
FC
,
ICC
,
IHC
,
IP
,
RIA

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Mouse
Host Species
Rat
Recommended Dilution Buffer
Immunogen
Thioglycolate-induced peritoneal macrophages from C57BL/6 mice
Product Concentration
≥ 5.0 mg/ml
Endotoxin Level
< 1.0 EU/mg as determined by the LAL method
Purity
≥95% monomer by analytical SEC
>95% by SDS Page
Formulation
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
State of Matter
Liquid
Product Preparation
Functional grade preclinical antibodies are manufactured in an animal free facility using only in vitro protein free cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Storage and Handling
Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at ≤ -70°C. Avoid Repeated Freeze Thaw Cycles.
Regulatory Status
Research Use Only
Country of Origin
USA
Shipping
2 – 8° C Wet Ice
Additional Applications Reported In Literature ?
FA,
FC,
ICC,
IHC,
IP,
RIA
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Description

Specificity
Cl:A3-1 activity is directed against mouse F4/80.
Background
Macrophages play an important role in innate and adaptive immune system functions1. F4/80 antigen is a widely used cell-surface marker of murine macrophages1, 2 encoded by the Adgre1 locus3. F4/80 antigen is a G protein-coupled receptor with an extracellular domain containing repeated Epidermal Growth Factor-like calcium-binding domains and as such is a member of the EGF-TM7 protein family, which itself is a subfamily of the adhesion G protein-coupled receptors (ADGRE) family. F4/80 is thought to have dual adhesion and signaling functions due to its receptor domains and is known to be required for the differentiation of antigen-specific CD8+ T regulatory cells1 . Adgre1 null mutant mice have a dysregulated autoimmune response and regulatory T cell generation3. Additionally, unstimulated resting macrophages express F4/80 at higher levels than activated macrophages1.

Cl:A3-1 was generated by immunizing a rat with thioglycolate-induced peritoneal macrophages from C57BL/6 mice4. Spleen cells were fused with mouse myeloma cell line NS1. Cl:A3-1 does not bind to macrophages via Fc receptors and is not cytotoxic. Cl:A3-1 is able to modulate Listeria-induced cytokine signaling between macrophages and natural killer cells2.

Antigen Distribution
F4/80 is constitutively expressed on most macrophages, except those located in T cell areas and marginal zones of lymph nodes and spleen, as well as on some dendritic cells. Blood monocytes also express F4/80, but at low levels relative to mature macrophages.
Ligand/Receptor
N/A
NCBI Gene Bank ID
UniProt.org
Research Area
Adaptive Immunity
.
Immunology
.
Signal Transduction

References & Citations

1 Lin HH, Faunce DE, Stacey M, et al. J Exp Med. 201(10):1615-1625. 2005.
2 Warschkau H, Kiderlen AF. J Immunol. 163(6):3409-16. 1999.
3 Waddell LA, Lefevre L, Bush SJ, et al. Front Immunol. 9:2246. 2018.
4 Austyn JM, Gordon S. Eur J Immunol. 11(10):805-815. 1981.
5 Hume DA, Perry VH, Gordon S. Anat Rec. 210(3):503-512. 1984.
6 Perry VH, Hume DA, Gordon S. Neuroscience. 15(2):313-326. 1985.
7 Morris L, Graham CF, Gordon S. Development. 112(2):517-526. 1991.
8 Haidl ID, Jefferies WA. Eur J Immunol. 26(5):1139-1146. 1996.
FA
Flow Cytometry
ICC
IHC
Immunoprecipitation Protocol
RIA

Certificate of Analysis

Formats Available

- -
- -
No results found. Clear filters and try again?
Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.